BANK OF AMERICA CORP /DE/
BankPosition in ELVN — Enliven Therapeutics, Inc.
CIK 70858
CHARLOTTE, NC
Position in ELVN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,974,667
+$3,204,318 QoQ
Shares Held
98,023
+117.0% QoQ
Ownership
0.134%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#79
of 208 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in ELVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. ELVN ranks #142 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in ELVN
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,974,667 | 98,023 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,770,349 | 45,162 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $503,748 | 32,711 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $481,924 | 23,543 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $491,630 | 24,508 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $402,061 | 20,430 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $769,207 | 34,187 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,243,567 | 48,691 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $800,000 | 34,232 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $294,420 | 16,738 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $425,261 | 30,727 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $315,627 | 23,106 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $347,846 | 17,043 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $143,335 | 6,545 | Shares | Defined | 2023-05-12 | |
| No filing history on record for this holder in this stock. | ||||||